PLUS THERAPEUTICS, INC. — Director's Dealing 2024

May 10, 2024

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: PLUS THERAPEUTICS, INC. (PSTV)
CIK: 0001095981
Period of Report: 2024-05-08

Reporting Person: Petersen Greg (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2024-05-08	Common Stock	P	12255	$2.04	Acquired	36421	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2024-05-08	Warrants (Right to buy)	$1.79	A	24510	Acquired		Common Stock Warrants (24510)	Direct

Footnotes

F1: The expiration date for 12,255 of the warrants (Series A warrants) is May 8, 2029. The expiration date for the other 12,255 warrants (Series B warrants) is the one-year anniversary of the effectiveness of a registration statement covering the resale of shares of common stock underlying the Series B warrants.

F2: Half of the warrants are Series A warrants and the other half are Series B warrants.